Stay updated on SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Sign up to get notified when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Page updated to revision v3.0.2; a Back to Top link was removed. No significant changes to core content, pricing, stock, or time-based information.
    Difference
    0.2%
    Check dated 2025-09-15T00:18:41.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-07T20:43:23.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, particularly in Germany, South Korea, and Spain, while also removing previous location entries and some medical terminology related to drug classifications.
    Difference
    7%
    Check dated 2025-08-31T12:58:52.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T05:24:20.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T01:06:47.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-02T19:59:02.000Z thumbnail image

Stay in the know with updates to SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.